GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.00
+1.00 (2.50%)
Mar 10, 2026, 12:31 PM CST
-28.83%
Market Cap 1.66B
Revenue (ttm) 677.10M
Net Income (ttm) 28.86M
Shares Out 41.46M
EPS (ttm) 0.70
PE Ratio 57.14
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,125
Average Volume 15,338
Open 40.50
Previous Close 40.00
Day's Range 40.00 - 41.00
52-Week Range 39.20 - 67.10
Beta -0.24
RSI 18.61
Earnings Date Mar 13, 2026

About GeneFerm Biotechnology

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company offers microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as well... [Read more]

Sector Healthcare
Founded 1999
Employees 144
Stock Exchange Taipei Exchange
Ticker Symbol 1796
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.